In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sinovac Biotech Ltd.

http://www.sinovac.com/

Latest From Sinovac Biotech Ltd.

China's mRNA Shot Shows Benefits Over Older COVID Vaccines

Home-grown Chinese mRNA COVID-19 vaccines are more effective than domestic inactivated virus-based shots, new trial results show.

China Clinical Trials

As WHO Rings COVID Zero Alarm, Study Says China Vaccination 'Insufficient'

The WHO calls the "COVID Zero" containment policy that Beijing is doubling down on "unsustainable," while a new study has shed light on the potential cost of moving away from cutting transmissions to mitigating disease. 

China Coronavirus COVID-19

Beijing Expands COVID Testing; Stringent New COVID Policy Coming?

Beijing expands mass testing to more areas and Shanghai’s case fatally rate raises questions amid China deals with the worst outbreak in two years.

Coronavirus COVID-19 Policy

Boosters Miss Growth Expectations Despite China COVID Surge

While two Chinese companies gained domestic approvals for their recombinant protein and adenovirus-based COVID-19 shots as heterologous boosters in February, these currently only account for roughly 21% of all booster shots, showing the continued predominance of inactivated virus-based technology in the country.

China Coronavirus COVID-19
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Pharmaceuticals
    • Drug Delivery
    • Vaccines
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Other Names / Subsidiaries
    • Beijing Kexing Bioproducts
    • Sinovac Dalian Vaccine Technology Co., Ltd.
    • Sinovac (Cayman) Limited
UsernamePublicRestriction

Register